Prof. Dr. Mesut Şeker
Onkoloji
18+ Yıl Deneyim

Prof. Dr. Mesut Şeker

Specialist in medical oncology at Medipol Mega University Hospital, Istanbul. 18+ years of experience in solid tumors.

4500+Tamamlanan Vaka
96%Greft Sağkalımı
Turkish, Arab, European, African, Central AsianUyruk

Credentials & Education

Academic and clinical achievements

Eğitim
  • Doctor of Medicine (MD), Faculty of Medicine, Turkey
  • Specialty Training in Internal Medicine, Turkey
  • Subspecialty Training in Medical Oncology, Turkey
  • Professorship — Istanbul Medipol University
Sertifikalar
  • Turkish Medical Oncology Association — Member
  • American Society of Clinical Oncology (ASCO) — Member
  • European Society for Medical Oncology (ESMO) — Member
Araştırma & Yayınlar
  • Peer-reviewed publications in solid tumor treatment
  • Speaker at international oncology congresses
Uluslararası Deneyim
  • Multicenter international clinical trials
  • International patient programs at Medipol University Hospital
Prof. Dr. Mesut Şeker

Biography

About the doctor

Prof. Dr. Mesut Şeker is a senior medical oncologist at Medipol Mega University Hospital in Istanbul. With more than 18 years of clinical and research experience, his practice focuses on lung, breast, gastrointestinal and genitourinary cancers. He is a faculty member at Istanbul Medipol University and an active researcher with numerous peer-reviewed publications. International patients choose him for personalized, evidence-based cancer care and access to modern systemic therapies.

Modern oncology offers more options than ever. My role is to translate that science into the right plan for each patient.

Areas of Expertise

Specialized procedures and treatments

Lung Cancer

Targeted and immune therapy for non-small-cell and small-cell lung cancer.

Breast Cancer

Adjuvant and metastatic breast cancer treatment.

Gastrointestinal Cancers

Treatment of colorectal, stomach, pancreatic and liver cancers.

Genitourinary Cancers

Treatment of prostate, kidney and bladder cancers.

Immunotherapy

Immune checkpoint inhibitor therapy for advanced solid tumors.

Clinical Trials

Access to international clinical trials for eligible patients.

Patient Reviews

4.8 / 5(220)
May 2026

“Excellent care from start to finish. Dr. Şeker's plan made a real difference.”

K
Karim B.

Tunisia

Tedavi: lung cancer treatment
Nis 2026

“Highly experienced and very kind. The treatment was well coordinated.”

L
Layla M.

Saudi Arabia

Tedavi: breast cancer treatment
May 2026

“I am grateful for the team's expertise and constant support.”

A
Ahmed S.

Egypt

Tedavi: colorectal cancer treatment

Frequently Asked Questions

What patients want to know

Initial evaluation takes 2–3 days; treatment cycles are short, repeated every 2–3 weeks.

Yes. We provide a detailed online second opinion before travel.

Yes, when patients qualify. We assess eligibility case by case.

Yes. Arabic and English support is available throughout your care.

Yes. We coordinate follow-up scans and consultations with your home doctor.

Onkoloji

Prof. Dr. Mesut Şeker ile görüşmeye hazır mısınız?

Ücretsiz konsültasyonunuzu ayırtın ve Onkoloji alanında uzman Prof. Dr. Mesut Şeker ile ilk adımı atın.

WhatsApp'tan Yazın